QR-koodi

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.

The optimal clinical management of patients with antiphospholipid antibody syndrome (APS) is uncertain because of a lack of an underlying hypothesis to explain why antiphospholipid autoantibodies (aPL) form to such ubiquitous compounds as phospholipids (PL). In this paper, we demonstrate that many,...

Täydet tiedot

Tallennettuna:
Julkaisussa:J Clin Invest
Päätekijät: Hörkkö, S, Miller, E, Dudl, E, Reaven, P, Curtiss, L K, Zvaifler, N J, Terkeltaub, R, Pierangeli, S S, Branch, D W, Palinski, W, Witztum, J L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Clinical Investigation 1996
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507492/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8698874/
https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118854
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia